T1	Participants 684 782	19 subjects were treated with 50 mg/d and 14 with 150 mg/d of naltrexone hydrochloride for 4 weeks
T2	Participants 464 591	Thirty-three mentally retarded adults with autism and/or SIB participated in double-blind, placebo-controlled crossover studies
